Operational effectiveness – achieving greater efficiency and effectiveness in R&D operations

This article discusses the requirement for efficiency and effectiveness in R&D operations and how our work with one global pharmaceutical company has lead to a transformation in key functions.

Topics covered include:

• Effective regulatory submissions

• Data and safety review

• Clinical development plans and protocols

• Managing and contracting vendors

• Making it happen and measuring the results.

In the increasingly costly and complex environment of drug development the cost of getting it right is high but necessary if the commercial rewards are to be realised.

The cost of not getting it right is higher: not only due to the material cost - which can amount to millions of dollars of lost revenue from a delayed launch - but also the loss of creditability in the face of investors and regulators.

Our client, the head of R&D of a global pharmaceutical company, approached us with a question: "Are we effective, efficient and do we use industry best practice?"

Get the full Operational effectiveness in pharma article.

To find out how PA can help you improve your R&D operations, please contact us now.